• 발명특허
• /
• 제11권6호통권124호
• /
• pp.52-54
• /
• 1986

이 글은 최근 세계지적소유권기구(WIPO)에서 아시아지역 각국 특허청을 통하여 조사, 발간한 $\ulcorner$THE SITUATION OF INDUSTRIAL PROPERTY IN THE COUNTRIES OF ASIA AND THE PACIFIC$\lrcorner$를 기본 자료로 하여 작성한 것이다.

• 한국정보통신학회:학술대회논문집
• /
• 한국정보통신학회 2015년도 추계학술대회
• /
• pp.445-447
• /
• 2015

동북아시아의 정세는 일본, 중국, 필리핀, 베트남 등 동중국해 연안 국가 간 영토 분쟁, 북한의 연이은 핵실험 및 장거리 탄도미사일 발사 시험, 중국의 랴오닝급 항공모함 건조 등으로 인해 급변하고 있다. 특히 불안정한 북한의 상황, 중국의 해군력 증강을 통한 A2/AD(Anti-Access/Area Denial, 반접근/지역거부) 전략 등으로 인해 미국의 아시아 태평양 지역 안보 전략의 재검토가 불가피하게 되었다. 본 논문에서는 변경된 미국의 아시아 태평양 안보 전략과 미 해군 전력의 재배치 계획에 대해 조사 및 분석하고, 변화된 주변 환경이 우리의 안보에 미치는 영향에 대해 분석하였다.

• The Journal of Asian Finance, Economics and Business
• /
• 제9권8호
• /
• pp.7-17
• /
• 2022

The article discusses the problems caused by inflation in the developing Asia-Pacific region during the time of the worldwide pandemic and suggests innovative solutions to the problem. The reality is that some of the commodity groups from the consumer basket (e.g., non-seasonal fruits, electronics, furniture, hotel, and restaurant services, etc.) fail to reflect the needs of the low-income earners, which make the majority in developing countries. At the same time, the inflation targeting regime has become outdated and not reliable, because of uncontrolled exogenic factors (imported inflation, fluctuation in oil prices, supply chain disruption, Russia-Ukraine war, etc.) prevailing on endogenic factors and thus making it impossible to control the price stability, especially in developing countries. Since, the old-fashioned inflation index and inflation targeting mechanisms regrettably fail to fully reflect both the society and governmental/central banks' expectations, based on which we first should have better care and second create better policies; we propose to use a combination of already well-known indexes and policies, with the new statistical indicators, which reflects price fluctuations on the medication, utilities, and nutrition.

• 무역학회지
• /
• 제41권4호
• /
• pp.293-313
• /
• 2016

동아시아 지역은 FTA 확대로 인해 국경을 초월한 경제일체화가 진척되고 있고, 각국의 규제제도 개혁으로 기업활동의 자유는 높아지고 있으며, 국경을 초월한 공정간 분업이 진전되고 있는 등 무역네트워크의 고도화가 촉진되고 있다. 미국이 주도하는 다자간 FTA인 환태평양경제동반자협정(TPP)은 2016년 2월 4일 뉴질랜드 오클랜드에서 12개국이 협정문에 서명하였는데, 동아시아 무역네트워크의 변화가 예상된다. 본 연구에서는 TPP가 동아시아 무역네트워크에 미칠 영향에 관해 살펴보았다. 연구결과 TPP는 공급사슬의 글로벌화를 이끄는 규제 및 제도로써 공급사슬 구조를 변화시키고, 가치사슬에 긍정적인 효과를 야기한다. 이는 동아시아 무역네트워크에 상당한 영향을 미칠 것이며 참여기업의 경쟁력 강화로 이어질 것이다. 또한 TPP는 향후 아태자유무역지대(FTAAP)의 실현을 위한 토대가 될 것으로 보이는데, 무역의존도가 높은 한국은 이로 인해 변화할 동아시아 무역환경에 효과적으로 대처하기 위한 정책적 노력을 기울여야 할 것이다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제17권2호
• /
• pp.697-702
• /
• 2016

Background: The Asia-Pacific Breast Initiatives (APBI) I and II registries were established to collect safety data for patients with early stage breast cancer receiving adjuvant docetaxel-based regimens in the Asia-Pacific region. Materials and Methods: Data from the two registries were combined to perform a safety analysis. Participants in the registry were women with early stage operable breast cancer with an intermediate or high risk of recurrence. These women received adjuvant chemotherapy that included docetaxel between 2006 and 2011. Adverse events (AEs) were recorded and analyzed. Results: Data were collected from 3,224 patients from 13 countries. The mean dose intensity of docetaxel was 24.1, 22.7, $25.1mg/m^2/week$ among patients receiving docetaxel-based monotherapy, combination therapy and sequential therapy, respectively. Granulocyte colony-stimulating factor (G-CSF) was given with docetaxel to 41.8% of women and 20.6% of women receiving prophylactic antibiotics. Adverse events were reported in 86% of patients (anthracycline-containing regimens vs. non-anthracycline regimens; 87% vs. 80%). The most common adverse events were alopecia, nausea, neutropenia, vomiting, and myalgia. Adverse events NCI CTCAE ${\geq}$Grade 3 were reported in 45.4% of patients. Serious adverse events were reported in 13% of patients, of which 2.5% led to study discontinuation. Forty-six deaths (1.4%) were reported, with no significant difference between regimens. Conclusions: The safety parameters of adjuvant docetaxel therapy used to treat sequential Asian women were comparable to those reported in clinical trials evaluating the role of adjuvant docetaxel. No unusual adverse events linked to Asia-Pacific region patients were observed.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권11호
• /
• pp.6821-6832
• /
• 2013

Background: Soft-tissue sarcomas require tailored and multidisciplinary treatment and management. However, little is known about how sarcomas are treated and managed throughout the Asia-Pacific region. Materials and Methods: MEDLINE was systematically searched using prespecified criteria. Publications (previous 10 years) that reported tumour characteristics, treatment patterns, survival outcomes, and/or safety outcomes of patients with soft-tissue sarcoma were selected. Exclusion criteria were studies of patients <18 years of age; ${\leq}10$ patients; countries other than Australia, Hong Kong, Indonesia, Korea, Malaysia, New Zealand, Philippines, Singapore, Taiwan, or Thailand; >20% benign tumours; sarcomas located in bones or joints; gastrointestinal stromal tumour; Kaposi's sarcoma; or not reporting relevant outcomes. Results: Of the 1,822 publications retrieved, 35 (32 studies) were included. Nearly all patients (98%, 1,992/2,024; 31 studies) were treated with surgery, and more studies used adjuvant radiotherapy than chemotherapy (24 vs 17 studies). Survival outcomes and recurrence rates varied among the studies because of the different histotypes, sites, and disease stages assessed. Only 5 studies reported safety findings. Conclusions: These findings highlight the lack of specific data available about soft-tissue sarcomas in the Asia-Pacific region. Better efforts to understand how the sarcoma is managed and treated will help improve patient outcomes in the region.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권8호
• /
• pp.4935-4937
• /
• 2013

At the United Nations High-level Meeting on Non-communicable Disease Prevention and Control in 2011 the link between health and socioeconomic issues was raised, becoming a global political issue. Health equity is one challenge that has hitherto not been addressed directly, although there is a growing shared recognition that cancer in Asia is an urgent social issue. At the UICC-ARO we are working to promote and widen networks of individuals and organizations in Asia and involve them in cooperation for this purpose. As part of our current activities, we are addressing the question of the "Economic burden of cancer in Asian countries: How should we face the current situation?" from a variety of angles and seeking to bring together a wealth of multidisciplinary knowledge about cancer in Asia and its related socioeconomic factors. It is essential to ensure that the real picture of cancer in Asia, which is currently not accurately understood, is conveyed clearly to all concerned, and also that the differences between cancer in Asia and in the West are highlighted.

• East Asian Economic Review
• /
• 제22권2호
• /
• pp.177-215
• /
• 2018

Trump's withdrawal from the Trans-Pacific Partnership (TPP) and his "America First" trade agenda ignite a second round of interest in mega-free trade agreements in the Asia-Pacific. Countries are evaluating alternative trade policy actions in a post-TPP era. Using national real GDP gains estimated by a modified GTAP model to construct "preference ordering" for 10 Association of Southeast Asian Nations members and their six regional dialogue partners, this paper comes up with several policy-oriented findings. First, when multilateral agreements are not possible, countries are better off with a regional trading agreement than without one. Second, the Regional Comprehensive Economic Partnership is likely to have higher beneficial impacts than the Comprehensive and Progressive Agreement for Trans-Pacific Partnership. Third, for dual-track countries, implementing both agreements is better than each separately. Fourth, impacts of open regionalism are likely to be higher than those of a closed and reciprocal one. Going forward, this paper argues that countries should adopt a "multi-track, multi-stage" approach to trade policy.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권8호
• /
• pp.4461-4484
• /
• 2013

Cancer registration provides a firm basis for cancer control efforts and research into changing patterns of incidence, mortality, survival and prevalence is of obvious importance. Most of the countries of Asia have already published relevant data although the level of coverage and accuracy do vary a great deal both between and within countries. The present review concerns the relevant literature for the period 2008-2013, focusing on the types of research conducted and the conclusions that can be drawn with regard to what should be done in the future to translate the information available into effective intervention efforts to reduce the burden of disease. A major emphasis has been on determining variation in incidence and mortality/survival on the basis of ethnicity and socioeconomic as well as geographical background, as well as trends over time, either for cancer in general or specific organ sites. In addition a small number of papers focused on methodological, quality and cancer control issues, very pertinent to the future development of cancer registry based research.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권2호
• /
• pp.407-409
• /
• 2012

The ACTION (Asean CosTs In ONcology) Study will be one of the largest observational studies of the burden of cancer ever conducted in Asia. The study will involve 10,000 newly diagnosed patients with cancer and will be carried out across eight low- and middle income countries within the ASEAN region (Indonesia, Thailand, Malaysia, Cambodia, Myanmar, Viet Nam, Laos and the Philippines). Patients will be interviewed three times over 12 months to assess their health, use of health care services, out of pocket costs related to their illness, social and quality of life issues. The project is a collaboration between the George Institute for Global Health, the ASEAN Foundation and Roche. The aim of the study is to assess the health and socioeconomic impact of cancer on patients in ASEAN communities, and the factors that may impact on these outcomes.